Alzheimer disease conferences provide information regarding current research and trends in Alzheimer’s disease. The main topics discussed in conference Dementia vs. Alzheimer’s, Alzheimer's and the brain, Diagnosis and symptoms, the role of plaques and tangles, Research and progress, Alzheimer’s medication, Alzheimer’s imaging and clinical trials, Alzheimer’s pathophysiology, Use Of Animal Models, Pharmacological Studies.
Parkinson's disease is a neurodegenerative disorder that has an effect on predominately dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantial nigra. Symptoms normally develop slowly over years. The development of symptoms is often different from one person to another due to the diversity of the disease. People with Parkinson’ may experience: Tremor, mainly at rest and described as pill rolling tremor in hands. Other forms of tremor are possible Bradykinesia, Limb rigidity, Gait and balance problems.
Alzheimer’s is the sixth most common cause of death according to the Centers for Disease Control and Prevention (CDC) among U.S adults. It ranks fifth among causes of death for people 65 years and older. In a study it was found that in 2010 there were 4.7 million Americans over the age of 65 years suffering with Alzheimer’s disease. Researchers projected that there will be 13.8 million Americans with Alzheimer’s by 2050. According to CDC’s estimations over 90 percent of people with Alzheimer’s don’t see any symptoms until they are over 60 years old. As per the CDC about $259 billion was spent on Alzheimer’s and dementia care costs in the United States in 2017. The global market for Alzheimer’s and diagnostics by reach should reach over $6.2 billion by 2020.
Dementia vs. Alzheimer’s, Alzheimer's and the brain, Diagnosis and symptoms, the role of plaques and tangles, Research and progress, Alzheimer’s medication, Alzheimer’s imaging and clinical trials, Alzheimer’s pathophysiology, Pharmacological Studies, Parkinson pathophysiology, Epidemiology of Parkinson’s disease, Neurocognitive and Neuromuscular Disorders, Risk Factors of Parkinson’s disease, Diagnostic and Neuroimaging for Parkinson’s disease, Managing life with Parkinson’s disease, Novel therapeutics for Parkinson’s disease, Clinical Trials in Parkinson’s disease, Deep brain stimulation.
Neuroscientists, Neurologists, Directors, Physicians, Researchers, Professors, Industrial Experts, Neurosurgeons, Psychiatrist, Nutritional Scientists, Lecturers and Students
Parkinson’s disease Conferences 2021 | Alzheimer’s disease Conferences | Neuropsychology conferences | Molecular Neuroscience conferences | Psychology conferences | Neurodegenerative disease Conferences | Psychiatry Conferences | Psychology conferences Spain | Neuroimmunology Conferences Valencia | Neuroinformatics conferences |
Hotel NH Valencia Center, Carrer de Ricardo Micó, 1, 46009 València, Valencia, Spain